baber/WOPTO huggingface dataset:
Patent FI-921548-A0 (FI)
Inventor: OSHLACK BENJAMIN
IPC: A61K31/485
Filed: 1992-04-08
Abstract: A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and relative humidity elevated to a suitable level above ambient conditions until the coated dosage form attains a stabilized dissolution profile substantially unaffected by exposure to storage conditions of elevated temperature and/or elevated relative humidity. <IMAGE>
Patent FI-925640-A0 (FI)
Inventor: HULIN BERNARD
IPC: A61K31/505
Filed: 1992-12-11
Abstract: Certain 3-(phenyl, chroman-2-yl, benzofuran-5-yl or benzoxazol-5-yl)-2-(hydroxy or mercapto)propionic acid derivatives and analogs are useful as hypoglycemic and hypocholesterolemic agents.
Patent FI-932335-A0 (FI)
Inventor: HASLOP JOHN MARTIN
IPC: B42D15/10
Filed: 1993-05-21
Abstract: PCT No. PCT/GB91/02069 Sec. 371 Date Jun. 10, 1993 Sec. 102(e) Date Jun. 10, 1993 PCT Filed Nov. 22, 1991 PCT Pub. No. WO92/09444 PCT Pub. Date Jun. 11, 1992.An authenticatable item and security device carry a number of symbols (4A, 4B, 4C, 6A, 6B, 6C) identifiable to the naked eye, there being at least two sets of at least three symbols. All the symbols within a set are substantially identical, are positioned in a non-overlapping, regular geometric arrangement, and at least one common viewing angle of inclination, exhibit substantially the same optical performance, the optical performance varying with inclination viewing angle.
Patent FI-934587-A0 (FI)
Inventor: VIRVING NILS
IPC: B02C7/12
Filed: 1993-10-18
Abstract: A refining segment for a disc refiner for defibering and processing lignocellulose-containing fiber material. The refining segment has the shape of a circle sector and a refining surface with bars and intermediate grooves, which extend across substantially the entire refining surface. The bars are oblique in relation to the radius of the refining segment, and the angle of the bars in relation to said radius is greatest closest to the centre and thereafter decreases in radial outward direction. The angle closest to the centre shall be in the interval 20-45 DEG  and farthest out in the interval -10<o> to +20<o>. <IMAGE>
Patent FI-934899-A0 (FI)
Inventor: GURAK RONALD W
IPC: B65B13/18
Filed: 1993-11-05
Abstract: An article compression apparatus for used in an article strapping apparatus for compressing an article to be strapped at a workstation. The article compression apparatus comprises a transfer shaft mounted for extending between opposite sides of said workstation and carrier means at said opposite sides of said workstation and connected to opposite ends of said shaft for movement in unison with said shaft. The article compression apparatus further comprises drive means for rotating said shaft and a soft compression member traversing said work station an connected to said carrier means.
Patent FI-943754-A0 (FI)
Inventor: MEINERT HASSO
IPC: C07C17/395
Filed: 1994-08-15
Abstract: PCT No. PCT/DE93/00061 Sec. 371 Date Nov. 3, 1994 Sec. 102(e) Date Nov. 3, 1994 PCT Filed Jan. 21, 1993 PCT Pub. No. WO93/16974 PCT Pub. Date Sep. 2, 1993Described is a method for the purification of perfluorocarbons, or mixtures of perfluorocarbons, having impurities containing hydrogen and/or carbon-carbon double bonds. The impure perfluorocarbons or perfluorocarbon mixtures are reacted with strong aqueous bases in the presence of Ca2+ or Ba2+ ions and alcoholate ions together with secondary amines.
Patent FI-944879-A0 (FI)
Inventor: HOPPE MANFRED
IPC: C09D7/65
Filed: 1994-10-18
Abstract: The invention relates to a heat-curable coating system which contains no epoxide groups and is based on carboxyl-functional polyester resins and ss-hydroxyalkylamides and, if desired, further conventional additives, the coating system containing as binder resin (a) at least one saturated polyester having an acid number of 15 to 75 mg of KOH/g, an OH number of not more than 10 mg of KOH/g and a glass transition temperature of greater than 45 DEG C, which is composed of aliphatic diols and more than 80 mol% of isophthalic acid, and as crosslinking agent (b) at least one hydroxyalkylamide having at least two hydroxyalkyl groups. The invention also relates to a process for the preparation of heat-curable coating systems which contain no epoxide groups and are based on carboxyl-functional polyester resins, in which components a), b) and, if desired, further conventional additives of the coating system according to claims 1 to 11 are mixed in the melt at from 80 to 130 DEG C, discharged, granulated, ground and then screened to a particle size of less than 90  mu m. The invention relates finally to the use of the coating system.
Patent FI-945596-A0 (FI)
Inventor: EBETINO FRANK HALLOCK
IPC: A61K31/663
Filed: 1994-11-28
Abstract: The present invention relates to quaternary nitrogen-containing phosphate compounds, and the pharmaceutically-acceptable salts and esters thereof having the general structure:   <IMAGE>   wherein: Z is a saturated, unsaturated, or aromatic, monocyclic or polycyclic carbocycle or monocyclic or polycyclic heterocycle containing one or more heteroatoms selected from O, S, or N; Y is N+(R8)2 or C(R1)2 and when Y is C(R1)2, at least one R2 must be N+(R8)3; R1, R2, R5, and R8 are defined in claim 1, m and n are integers from 0 to 10; m+n is from 0 to 10; R is COOH; PO3H2; SO3H; or P(O)(OH)R4, wherein R4 is substituted or unsubstituted alkyl of 1-8 carbons atoms. The present invention further relates to pharmaceutical compostions containing a safe and effective amount of a compound of the present invention, and pharmaceutically-acceptable excipients. Finally, the present invention relates to methods for treating or preventing pathological conditions characterized by abnormal calcium and phosphate metabolism such as osteoporosis, rheumatoid arthritis, and osteoarthritis in humans or other mammals and to methods for treating or preventing dental calculus, plaque, and gingivitis.
Patent FI-952442-A0 (FI)
Inventor: FRICK ALEXANDER
IPC: B64C29/00
Filed: 1995-05-19
Abstract: A flight device that can be placed upon and fastened to a load, which may be a pilot (P) or a remote guided control device, comprises a bearing device that can be fastened to the load, a drive unit (100) that has a piston engine and that is coupled with a rotary drive shaft (108) directly to an impeller (200') of a supercharger (200) for generating an airflow, and at least two propulsion pipes (300) that end in air-outlet nozzles (304, 305) which are arranged laterally on either side of the load or pilot (P) and which can be adjusted to change the direction of the emerging airflow. The supercharger (200) has an intake cone (202) which in the normal attitude of flight is situated essentially in a horizontal position above the pilot (P) or load. The rotary drive shaft (108) to drive the supercharger (200) is then essentially vertical and the outlet nozzles (304, 305) are then arranged essentially in a plane containing the vertical cg axis (X). The airflow generated by the impeller (200') of the supercharger (200) is expelled through the propulsion pipes (300) at subsonic speed.
Patent FI-954883-A0 (FI)
Inventor: BJOERK SETH
IPC: A61K9/16
Filed: 1995-10-13
Abstract: PCT No. PCT/SE94/00331 Sec. 371 Date Oct. 11, 1995 Sec. 102(e) Date Oct. 11, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/23703 PCT Pub. Date Oct. 27, 1994Porous cellulose matrices with a defined particle size and a significantly higher porosity (i.e. pore volume) than conventional formulations, such as pellet formulations containing cellulose and binders are prepared. The cellulose is mechanically treated with low adhesion to the process equipment during a controlled gradual addition of an aqueous based fluid, optionally containing a surface-active ingredient, into regular particles, which are finally dried to obtain dry porous cellulose matrices. The so obtained matrices can be used as carriers for bioactive substances in multiple-unit preparations or tablets.
Patent FI-960026-A0 (FI)
Inventor: MUELLER REINHARD
IPC: C09K23/00
Filed: 1996-01-03
Abstract: The invention concerns agents for the dyeing of keratin-containing fibres, in particular human hair, said agents containing 2,4,5,6-tetraaminopyrimidines, the usual coupling compounds and selected direct-dyeing agents. Particularly suitable direct-dyeing agents are 6-chloro-4-nitro-2-aminophenol, 5-chloro-4-(2-hydroxyethyl)amino-2-nitroaniline, 1,4-bis-[(2,3-dihydroxypropyl)amino]-5-chloro-2-nitrobenzene and 1-(2-hydroxyethyl)amino-4-methyl-2-nitrobenzene.
Patent FI-971625-A0 (FI)
Inventor: LEINONEN JOUKO
IPC: C21D1/42
Filed: 1997-04-17
Abstract: Heat treatment of low-carbon, unalloyed or low-alloyed steels includes one or more cycles, in which the steel is heated (S1) to a temperature (Tp) above the Ac3 temperature and is cooled back to a temperature (Te1, Te3) below the Ac1 temperature or a higher temperature, at which not more than one half of the structure of the steel consists of austenite, so that the holding time (td) above the Ac3 temperature is typically of the order of a few seconds or a few tens of seconds, and not more than 5 minutes. Heat treatment is carried out as the last stage in which the temperature is elevated to the Ac3 temperature. Preferably, the heating is started from a temperature (Ts1) in the range 500 to 720  DEG C, and the temperature (Tp) above the Ac3 temperature is 850 to 1050  DEG C. By the heat treatment of the invention strength and impact thoughness of steel is improved. A preferred application of the invention is heat treatment of a weld joint or a welded structure.
Patent FI-973418-A0 (FI)
Inventor: HAAHEIM LARS REINHARDT
IPC: G01N33/53
Filed: 1997-08-20
Abstract: PCT No. PCT/GB96/00392 Sec. 371 Date Aug. 21, 1997 Sec. 102(e) Date Aug. 21, 1997 PCT Filed Feb. 21, 1996 PCT Pub. No. WO96/26443 PCT Pub. Date Aug. 29, 1996The present invention provides a method of detecting active antibody production in a blood sample by contacting, in the presence and absence of protein synthesis inhibitor, aliquots of the sample with a solid phase under conditions which permit antibody production and secretion by the lymphocytes; detecting in solution, binding of antibody to the antigen(s) on the solid phase; and comparing the antibody binding in the presence or absence of protein synthesis inhibitor, whereby to obtain a determination of the amount of active antibody secretion in response to the antigen(s); and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.
Patent IL-81838-A0 (IL)
Title: Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors,dna fragments and recombinants for use in the production of said cells and plants
IPC: C12N5/10
Filed: 1987-03-10
Abstract: A process for controlling the action in plant cells and plants of a glutamine synthetase inhibitor (I) comprises providing the plants with a heterologous DNA including a foreign nucleotide sequence, capable of being expressed in the form of a protein in the plant cells and plants, under conditions such as to cause the heterologous DNA to be integrated stably through generations in the cells of the plants, and where the protein has an enzymatic activity capable of causing inactivation or neutralisation of (I). Pref. the heterologous DNA fragment comprises a foreign nucleotide sequence coding for a polypeptide having phosphinothricin (PPT) acetyl transferase activity.
Patent IL-87066-A0 (IL)
Title: Auxiliary combustion chamber for supercharged internal combustion engine and engines equipped with such a chamber
IPC: F23R3/00
Filed: 1988-07-11
Abstract: PCT No. PCT/FR88/00385 Sec. 371 Date Mar. 16, 1989 Sec. 102(e) Date Mar. 16, 1989 PCT Filed Jul. 25, 1988 PCT Pub. No. WO89/01090 PCT Pub. Date Feb. 9, 1989.The primary zone (1) of the auxiliary combustion chamber has a shape of revolution about an axis (X-X) and is defined by a flame tube (2) which is of cylindrical and/or frustoconical shape, coaxial with said axis (X-X), smooth and devoid of air supply orifices of notable section, and by the chamber inner end (3) which is movable in a direction parallel to said axis (X-X) and cooperates with a fixed seat (13) rigidly connected to the flame tube (2) and separating the primary zone (1) from a cavity (4) so as to constitute, with the chamber inner end (3), throttling means (31) which have a variable passage section and are constituted by a sleeve (10) rigidly connected to a balancing piston (11), which sleeve and piston are coaxial with said axis (X-X), the balancing piston (11) being slidable in a cylindrical bearing surface (12) rigidly connected to the walls of the cavity (4). The inlet of the fuel under pressure is constituted by at least one nozzle (14) which is arranged in said sleeve (10) in such manner as to open out toward the primary combustion zone (1).
Patent IL-89942-A0 (IL)
Title: Heterotetracyclic lactam derivatives
IPC: C07D487/16
Filed: 1989-04-13
Abstract: Disclosed are the compounds of formula I <CHEM> wherein R1-R3 represent hydrogen or lower alkyl; m represents the integer 2 or 3; n represents the integer 1 or 2; Het represents a pyrrole or imidazole ring bonded at any two adjacent positions and optionally substituted by one or two of lower alkyl; and pharmaceutically acceptable salts of compounds of formula I wherein Het represents optionally substituted imidazole; their methods of preparation; pharmaceutical compositions thereof, and their use for treating cognitive disorders in mammals. They can be prepared for example by condensing a compound of the formula  Het min -(CH2)m-NH2  with a compound of the formula <CHEM> R
Patent IL-90875-A0 (IL)
Title: Diagnosing and treating viral infections associated with chronic fatigue
IPC: C12Q1/6883
Filed: 1989-07-05
Abstract: Chronic Fatigue Syndrome is diagnosed and distinguished from other conditions presenting a similar clinical appearance by assessing the 2 min -5 min A oligonucleotide levels in the patient's circulating peripheral leucocytes and comparing the result obtained to that of healthy individuals. Double-stranded RNAs, notably mismatched dsRNAs, when administered in appropriate amounts, increase the 2 min -5 min A in patients with Chronic Fatigue Syndrome to normal levels and improve the clinical symptoms.
Patent IL-96893-A0 (IL)
Title: Vaccines against cancer and infectious diseases
IPC: A61K39/39
Filed: 1991-01-07
Abstract: A method of stimulating an immune response in a human against malignant cells or an infectious agent comprises the step of administering to the human an immunogenic amount of a primate anti-idiotype antibody or antibody fragment that acts as an immunogenic functional mimic of an antigen produced by or associated with a malignant cell or an infectious agent. Sub-human primate anti-idiotype antisera, especially from baboons, are preferred. Such anti-idiotype antibodies are used to make vaccines for inducing preventive immunity or a therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites.
Patent FI-20115815-A0 (FI)
Inventor: MERTALA ANTTI
IPC: B66B/
Filed: 2011-08-22
Abstract: The object of the invention is a compensating arrangement for the suspension members of an elevator, which arrangement comprises at least an elevator car (1) configured to move up and down in an elevator hoistway and at least two compensating weights (2a, 2b), which are for their part connected to support the elevator car (1) by the aid of at least one suspension member (3), such as by the aid of a rope or belt and also by the aid of diverting pulleys (4), and a hoisting machine (6) provided with at least one traction sheave (5) or corresponding, as well as at least two traction members (7a, 7b), such as belts, ropes or chains, which transmit the rotational movement of the traction sheave (5) into movement of the elevator car (1) and of the compensating weights (2a, 2b). The suspension members (3) are fixed at their first ends to at least one compensating weight (2, 2a), led to pass via one or more diverting pulleys (4a-4d) on the elevator car (1) to at least one second compensating weight (2, 2b) and fixed at their second ends to at least the aforementioned second compensating weight (2, 2b).
Patent IL-117820-A0 (IL)
Title: Article selection and delivery method and apparatus
IPC: B65H3/08
Filed: 1996-04-03
Abstract: A partition inserter has a vacuum assembly which pivots out to contact an end partition in a stack, pivots back to remove the partition, and then moves downwardly to release the partition. The positioning of the vacuum assembly is controlled by a set of cams and a cam follower for controlling the horizontal position of the vacuum assembly and a third cam and cam follower for controlling the vertical position of the vacuum assembly. The vacuum assembly has an upper set of cups which move down with the assembly to lower the partition. The upper vacuum cups are also adjustably mounted to the assembly so that the same assembly may be used for partitions of various sizes. When the partition is released from the vacuum cups, the partition is guided downwardly by a pair of conveyors to a set of shooter wheels. The conveyor and shooter wheels are mounted to a set of plates which are adjustably mounted to the frame of the apparatus. The distance between the conveyors and shooter wheels can be adjusted to equal the width of the partition.
Patent IL-123899-A0 (IL)
Title: Process for the purification of dimethyl sulphoxide (DMSO)
IPC: C07C315/06
Filed: 1996-11-15
Abstract: PCT No. PCT/FR96/01806 Sec. 371 Date May 12, 1998 Sec. 102(e) Date May 12, 1998 PCT Filed Nov. 15, 1996 PCT Pub. No. WO97/19057 PCT Pub. Date May 29, 1997This process consists in placing liquid DMSO with a low water content in contact with an ion exchange resin in -SO3H form, and then in separating the liquid from the resin. The DMSO thus obtained has a content of iron cation tracer element of less than or equal to 1 ppb and a content of Na cation tracer element of less than or equal to 2 ppb.
Patent IL-125444-A0 (IL)
Title: Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives
IPC: A61K31/4375
Filed: 1997-02-12
Abstract: The present invention relates to novel optionally substituted 8-cyano-1-cyclo-propyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives, of the general formula (I)in whichR1 represents hydrogen, C1-C4-alkyl which is optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl,R2 represents hydrogen, benzyl, C1-C3-alkyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, radicals having the structures -CH=CH-COOR3, -CH2CH2COOR3, -CH2CH2CN, -CH2CH2COCH3 or -CH2COCH3, in which R3 represents methyl or ethyl, or a radical of the general structure R4-(NH-CHR5-CO)n-, in which R4 represents hydrogen, C1-C3-alkyl or the radical -COO-tert-butyl, R5 represents hydrogen, C1-C4-alkyl, hydroxyalkyl, aminoalkyl, thioalkyl, carboxyalkyl or benzyl and n is 1 or 2, andY is oxygen or sulfur,the process for their preparation and their use in antibacterial compositions.
Patent IL-134090-A0 (IL)
Title: Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
IPC: A61K31/385
Filed: 1998-07-22
Abstract: Compositions of GLA and/or other EFAs with TA or related compounds, and their use in therapy or nutrition or in preparation of compositions for therapy or nutrition, especially to improve cell membrane EFA concentration and impaired nerve function and blood flow.
Patent IL-151628-A0 (IL)
Title: Combination therapies with vascular damaging activity
IPC: A61K31/66
Filed: 2001-03-27
Abstract: The invention relates to a method for the production of a vascular damaging effect in a warm-blooded animal such as a human, which comprises administering to said animal an effective amount of ZD6126 or a pharmaceutically acceptable salt thereof, before, after or simultaneously with an effective amount of one of the following therapies: i) ionizing radiation; ii) a platinum anti-tumor agent; and iii) a taxane. The invention also relates to the use of ZD6126 and one of the above therapies in the manufacture of a medicament for use in the production of a vascular damaging effect in a warm-blooded animal such as a human and to pharmaceutical compositions and kits each comprising ZD6126 and one of a platinum anti-tumor agent and a taxane
Patent IL-151792-A0 (IL)
Title: Method and composition for removing sodium-containing material from microcircuit substrates
IPC: H01L21/304
Filed: 2001-03-19
Abstract: A method and composition for removing sodium-containing materials such as photoresist from microcircuit substrate material utilizes 1,2-Diaminocyclohexanetetracarboxylic Acid in an organic solvent.
Patent IL-151987-A0 (IL)
Title: Nuclear factor kb inducing factor
IPC: A61K39/395
Filed: 2001-04-02
Abstract: The present invention is directed to nuclear factor kB (NFkB)-inducing factor polypeptides (NFIF polypeptides) which are capable of inducing NKkB. The present invention includes within its scope NFIF polypeptides, including NFIF-14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included are methods and compositions for increasing NFkB induction in a patient, methods and compositions for lowering NFkB induction in a patient, methods for inhibiting inflammation, and methods for manufacture of a medicament intended for the treament and/or prevention of an NFkB-regulated inflammatory response. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided.
Patent IL-153660-A0 (IL)
Title: Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
IPC: C12N15/87
Filed: 2001-06-27
Abstract: Introducing a biologically active molecule (I) into the nucleus of eukaryotic cells, comprising applying an electrical pulse of field strength 2-10 kV/cm; duration at least 10 Micros and current at least 1 Amp, is new. - ACTIVITY : None given. - MECHANISM OF ACTION : Gene therapy. No biological data is given.
Patent IL-155512-A0 (IL)
Title: Apparatus and method for protecting printing heads
IPC: B41J29/08
Filed: 2001-10-22
Abstract: Apparatus and method for protecting print heads from uncontrolled movement and vibration is provided. The apparatus includes at least one print head, a movable component attachable to a flexible cable carrier, the flexible cable carrier being coupled to at least one print head, and an isolating component attachable to the movable component, for isolating uncontrolled movement and vibration of the flexible cable carrier from the at least one print head.
Patent IL-159910-A0 (IL)
Title: Pulsed electric shaver
Inventor: SHALEV PINCHAS
IPC: A45D26/00
Filed: 2002-07-21
Abstract: A hair cutting apparatus comprising a structure (1260), a portion (1216) of which being adapted for placement against a skin surface where hair is to be cut, a heat generator comprising one or more heat elements (1214) heated to a temperature sufficient to cut hair, at least one of said heat elements being juxtaposed with said portion and positioned to touch said skin and a controller that controls said heat generator to prevent heat from being applied continuously in a single area for sufficient time to cause skin damage.